| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Purchases of property and equipment | 823 | 463 | 196 | 934 |
| Other, net | 52 | 38 | 25 | 96 |
| Net cash used in investing activities | -1,808 | -584 | 103 | -3,529 |
| Proceeds from long-term borrowings | 2,994 | 0 | - | 2,580 |
| Repayments of long-term borrowings | 2,150 | 1,250 | 1,250 | 800 |
| Proceeds from short-term borrowings | 990 | - | 0 | 210 |
| Repayments of short-term borrowings, net of issuances | 1,175 | 5 | 115 | 75 |
| Changes in securities lending payable | 576 | 466 | 290 | 158 |
| Changes in bank overdrafts | 77 | 631 | 546 | -172 |
| Repurchase and retirement of common stock | 2,134 | 1,258 | 880 | 1,089 |
| Cash dividends | 1,152 | 771 | 386 | 1,135 |
| Proceeds from issuance of common stock under employee stock plans | 21 | 21 | 23 | 205 |
| Taxes paid through withholding of common stock under employee stock plans | 31 | 40 | 123 | 106 |
| Other, net | 10 | -11 | -14 | 9 |
| Net cash used in financing activities | -1,974 | -2,217 | -1,909 | -215 |
| Effect of foreign exchange rates on cash and cash equivalents | 1 | 2 | 1 | 2 |
| Change in cash and cash equivalents | 425 | 272 | -788 | 1,360 |
| Cash and cash equivalents at beginning of period | 8,288 | 8,288 | 8,288 | - |
| Cash and cash equivalents at end of period | 8,713 | 8,560 | 7,500 | - |
Elevance Health, Inc. (ELV)
Elevance Health, Inc. (ELV)